merck glp-1 drug medication and its types Novo inks Ascendis deal to

4k, l, Table 1)

The decreased risk of heart failure associated with SGLT-2 inhibitors may be imparted by their haemodynamic effects on the heart, such as reduced intravascular volume, improved arterial elasticity, and decreased cardiac preload and afterload.4041 Concerning their renoprotective effects, SGLT-2 inhibitors ameliorate hyperfiltration in the proximal tubules, which reduces intraglomerular pressure.42 Thus, the decreased cardiorenal risk associated with the combined use of GLP-1 receptor agonists and SGLT-2 inhibitors may be attributed to an additive effect, achieved by the distinct mechanisms and sites of action for these different drug classes

Additionally, besides its effective role in weight reduction, tirzepatide has demonstrated improvements in cardiovascular metabolic risk factors

The following checklist operationalizes the Stabilize Calibrate Accelerate Preserve framework introduced earlier in this guide

It also became evident that utilizing such combination therapy might result in a more effective strategy toward curtailing cardiometabolic risks rather than relying on individual treatments alone